XML 33 R18.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Accumulated Other Comprehensive Income (Loss) and Shareholders' Equity | 12 Months Ended
--- | ---
Dec. 30, 2023
Equity [Abstract] |
Accumulated Other Comprehensive Income (Loss) and Shareholders' Equity | Accumulated Other Comprehensive Income (Loss) and Shareholders’ Equity Accumulated Other Comprehensive Income (Loss) The following table summarizes the components of accumulated other comprehensive income (loss) and the changes in accumulated other comprehensive income (loss), net of tax, as applicable:
| Foreign Currency Translation Adjustment |  | Unrealized Gains (Losses) on Debt Securities |  | Pension and Post-retirement Liabilities |  | Derivative Financial Instruments |  | Accumulated Other Comprehensive Income (Loss)
Balance as of January 2, 2021 | $ | (1.1) |  |  | $ | 0.4 |  |  | $ | (6.7) |  |  | $ | (1.8) |  |  | $ | (9.2) |
Other comprehensive income (loss) before reclassifications | 0.4 |  |  | (0.3) |  |  | 1.2 |  |  | 0.4 |  |  | 1.7 |
Tax (expense) or benefit | — |  |  | 0.1 |  |  | (0.3) |  |  | (0.1) |  |  | (0.3) |
Amounts reclassified from accumulated other comprehensive income (loss), net of tax | — |  |  | (0.0) |  |  | 0.3 |  |  | 0.7 |  |  | 1.1 |
Balance as of January 1, 2022 | $ | (0.7) |  |  | $ | 0.1 |  |  | $ | (5.4) |  |  | $ | (0.7) |  |  | $ | (6.8) |
Other comprehensive income (loss) before reclassifications | (2.4) |  |  | (0.9) |  |  | 5.3 |  |  | 1.1 |  |  | 3.2 |
Tax (expense) or benefit | — |  |  | 0.2 |  |  | (1.3) |  |  | (0.3) |  |  | (1.3) |
Amounts reclassified from accumulated other comprehensive income (loss), net of tax | (3.3) |  |  | (0.0) |  |  | 0.2 |  |  | (0.0) |  |  | (3.1) |
Balance as of December 31, 2022 | $ | (6.4) |  |  | $ | (0.6) |  |  | $ | (1.1) |  |  | $ | 0.1 |  |  | $ | (8.0) |
Other comprehensive income (loss) before reclassifications | (0.2) |  |  | 0.3 |  |  | (0.2) |  |  | (3.4) |  |  | (3.5) |
Tax (expense) or benefit | — |  |  | (0.1) |  |  | 0.1 |  |  | 0.8 |  |  | 0.8 |
Amounts reclassified from accumulated other comprehensive income (loss), net of tax | — |  |  | 0.1 |  |  | 0.1 |  |  | (0.2) |  |  | 0.0 |
Balance as of December 30, 2023 | $ | (6.5) |  |  | $ | (0.3) |  |  | $ | (1.2) |  |  | $ | (2.7) |  |  | $ | (10.6) |
Amounts in parentheses indicate reductions to equity. Interest Rate Swap During the normal course of business, the Corporation is subjected to market risk associated with interest rate movements. Interest rate risk arises from variable interest debt obligations. Interest rate swap derivative instruments are periodically held and used by the Corporation as a tool for managing interest rate risk. They are not used for trading or speculative purposes. In November 2023, the Corporation entered into a new interest rate swap transaction to hedge $100 million of outstanding variable rate term loan borrowings against future interest rate volatility. Under the terms of this interest rate swap, the Corporation pays a fixed rate of 4.7 percent and receives one-month SOFR on a $100 million notional value expiring June 2027. As of December 30, 2023, the fair value of the Corporation’s interest rate swap liability was $3.5 million; see "Note 9. Fair Value Measurements of Financial Instruments." The unrecognized change in value of the interest rate swap is reported net of tax as $2.7 million in "Accumulated other comprehensive income (loss)" in the Consolidated Balance Sheets. In April 2022, the Corporation terminated its prior interest rate swap agreement and received cash proceeds of $0.4 million, the fair value of the swap on the termination date. The proceeds were recorded as cash provided by operating activities in the Consolidated Statements of Cash Flows. The $0.4 million gain from the termination of this interest rate swap agreement was recorded to "Accumulated other comprehensive income (loss)" and was amortized to interest expense through April 2023, the remaining term of the original interest rate swap agreement. The following table details the reclassifications from accumulated other comprehensive income (loss):
Details about Accumulated Other Comprehensive Income (Loss) Components |  | Affected Line Item in the Statement Where Net Income is Presented |  | 2023 |  | 2022 |  | 2021
Derivative financial instruments |  |  |  |  |  |  |  |
Interest rate swaps |  | Interest expense, net |  | $ | 0.2 |  |  | $ | 0.1 |  |  | $ | (1.0) |
|  | Income tax expense |  | (0.1) |  |  | (0.0) |  |  | 0.2 |
Unrealized gains (losses) on debt securities |  |  |  |  |  |  |  |
Gain (loss) on sale of debt securities |  | Selling and administrative expenses |  | (0.1) |  |  | 0.0 |  |  | 0.0 |
|  | Income tax expense |  | 0.0 |  |  | (0.0) |  |  | (0.0) |
Pension and post-retirement liabilities |  |  |  |  |  |  |  |
Amortization of loss |  | Selling and administrative expenses |  | (0.1) |  |  | (0.3) |  |  | (0.5) |
|  | Income tax expense |  | 0.0 |  |  | 0.1 |  |  | 0.1 |
Foreign currency translation |  |  |  |  |  |  |  |
Lamex divestiture |  | Gain on sale of subsidiary |  | — |  |  | 3.3 |  |  | — |
|  | Net of tax |  | $ | (0.0) |  |  | $ | 3.1 |  |  | $ | (1.1) |
Amounts in parentheses indicate reductions to profit. Director Plan In May 2017, the Corporation registered 0.3 million shares of its common stock under its 2017 Equity Plan for Non-Employee Directors of HNI Corporation (the "2017 Director Plan"). The 2017 Director Plan permits the Corporation to issue to its non-employee directors options to purchase shares of Corporation common stock, restricted stock or restricted stock units of the Corporation, and awards of Corporation common stock. The 2017 Director Plan also permits non-employee directors to elect to receive all or a portion of their annual retainers and other compensation in the form of shares of Corporation common stock. Shares of common stock issued under the Director Plan in 2023, 2022, and 2021, were 43 thousand, 32 thousand, and 25 thousand, respectively.
Dividend The Corporation declared and paid cash dividends per common share as follows:
| 2023 |  | 2022 |  | 2021
Dividends per common shares | $ | 1.28 |  |  | $ | 1.27 |  |  | $ | 1.24 |
Members’ Stock Purchase Plan During 2017, shareholders approved the HNI Corporation Members’ Stock Purchase Plan (the "2017 MSPP"). Under the 2017 MSPP, 0.8 million shares of common stock were registered for issuance to participating members. Under the 2017 MSPP, rights to purchase stock are granted on a quarterly basis to all participating members who customarily work 20 hours or more per week and for five months or more in any calendar year. The price of the stock purchased under the MSPP is 85 percent of the closing price on the exercise date. No member may purchase stock under the MSPP in an amount which exceeds a maximum fair value of $25,000 in any calendar year. Shares of common stock issued under the MSPP in 2023, 2022, and 2021, were 77 thousand, 88 thousand, and 68 thousand, respectively. The following table provides the average price per share issued under the MSPP:
| 2023 |  | 2022 |  | 2021
Average price per share | $ | 27.15 |  |  | $ | 26.50 |  |  | $ | 34.49 |
An additional 0.3 million shares were available for issuance under the 2017 MSPP as of December 30, 2023. Change in Control The Corporation has entered into change in control employment agreements with certain officers. According to the agreements, a change in control occurs when a third person or entity becomes the beneficial owner of 20 percent or more of the Corporation’s common stock, when more than one-third of the Board is composed of persons not recommended by at least three-fourths of the incumbent Board, upon certain business combinations involving the Corporation, or upon approval by the Corporation’s shareholders of a complete liquidation or dissolution. Upon a change in control, a key member is deemed to have a two-year employment agreement with the Corporation, and all of his or her benefits vest under the Corporation’s compensation plans. If, at any time within two years of the change in control, his or her employment is terminated by the Corporation for any reason other than cause or disability, or by the key member for good reason, as such terms are defined in the agreement, then the key member is entitled to receive, among other benefits, a severance payment equal to two times (three times for the Corporation’s Chairman, President, and Chief Executive Officer) annual salary and the average of the prior two years’ bonuses. Stock Repurchase The par value method of accounting is used for common stock repurchases. The following table summarizes shares repurchased and settled by the Corporation:
| 2023 |  | 2022 |  | 2021
Shares repurchased | 0.0 |  |  | 1.7 |  |  | 1.5 |
Average price per share | $ | 41.98 |  |  | $ | 38.11 |  |  | $ | 39.89 |
Cash purchase price | $ | (0.4) |  |  | $ | (63.9) |  |  | $ | (60.4) |
Purchases unsettled as of year end | 0.1 |  |  | — |  |  | 1.3 |
Prior year purchases settled in current year | — |  |  | (1.3) |  |  | — |
Shares repurchased per cash flow | $ | (0.3) |  |  | $ | (65.2) |  |  | $ | (59.2) |
As of December 30, 2023, approximately $233.5 million of the Board’s current repurchase authorization remained unspent.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration